These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 42624)

  • 1. Solid phase synthesis of the protected 27--42 hexadecapeptide of the heavy chain from myeloma immunoglobulin M603. Elimination of side reactions associated with glycyl-2-oxypropionyl-resin.
    Tjoeng FS; Tam JP; Merrifield RB
    Int J Pept Protein Res; 1979; 14(3):262-74. PubMed ID: 42624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of the protected tridecapeptide (56-68) of the VH domain of mouse myeloma immunoglobulin M603 and its reattachment to resin supports.
    Voss C; Dimarchi R; Whitney DB; Tjoeng FS; Merrifield RB; Tam JP
    Int J Pept Protein Res; 1983 Aug; 22(2):204-13. PubMed ID: 6618764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase synthesis of the protected 43-55 tridecapeptide of the heavy chain of myeloma immunoglobin M603, employing cyclohexyl ester protection for glutamic acid.
    Dimarchi RD; Tam JP; Merrifield RB
    Int J Pept Protein Res; 1982 Mar; 19(3):270-9. PubMed ID: 6811468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptides VH(27-68) and VH(16-68) of the myeloma immunoglobulin M603 heavy chain and their association with the natural light chain to form an antigen binding site.
    Kubiak T; Whitney DB; Merrifield RB
    Biochemistry; 1987 Dec; 26(24):7849-55. PubMed ID: 3122833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative solid-phase Edman degradation for evaluation of extended solid-phase peptide synthesis.
    Matsueda GR; Haber E; Margolies MN
    Biochemistry; 1981 Apr; 20(9):2571-80. PubMed ID: 6786336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent solid-phase peptide synthesis. VIII. Synthesis, using a photolabile resin, and purification of a methionine-containing protected peptide.
    Lloyd-Williams P; Albericio F; Giralt E
    Int J Pept Protein Res; 1991 Jan; 37(1):58-60. PubMed ID: 2045220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis with attachment of peptide to resin through an amino acid side chain: (8-lysine)-vasopressin.
    Meienhofer J; Trzeciak A
    Proc Natl Acad Sci U S A; 1971 May; 68(5):1006-9. PubMed ID: 5280519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photolabile multi-detachable p-alkoxybenzyl alcohol resin supports for peptide fragment or semi-synthesis.
    Tam JP; Dimarchi RD; Merrifield RB
    Int J Pept Protein Res; 1980 Nov; 16(5):412-25. PubMed ID: 7216616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of protected secretin 16-27 on a Merrifield resin. Examination of ammonolysis conditions for preparing carboxamide terminal protected peptides suitable for fragment condensation.
    Wright DE; Agarwal NS; Hruby VJ
    Int J Pept Protein Res; 1980 Mar; 15(3):271-8. PubMed ID: 7380611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of crown ethers in peptide chemistry-V. Solid-phase synthesis of peptides by the fragment condensation approach using crown ethers as non-covalent protecting groups.
    Botti P; Ball HL; Lucietto P; Pinori M; Rizzi E; Mascagni P
    J Pept Sci; 1996; 2(6):371-80. PubMed ID: 9230465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin A. Arrangement of disulfide bridges in the "hinge" region of an immunoglobulin lin A-1 human myeloma protein.
    Wolfenstein-Todel C; Prelli F; Frangione B; Franklin EC
    Biochemistry; 1973 Dec; 12(25):5195-7. PubMed ID: 4601226
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein.
    Rudikoff S; Potter M
    Biochemistry; 1974 Sep; 13(19):4033-8. PubMed ID: 4213527
    [No Abstract]   [Full Text] [Related]  

  • 13. Amino acid sequence of the variable region of the light (lambda) chain from human myeloma cryoimmunoglobulin IgG Hil.
    Lopez de Castro JA; Chiu YY; Poljak RJ
    Biochemistry; 1978 May; 17(9):1718-23. PubMed ID: 418804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid phase synthesis without repetitive acidolysis. Preparation of leucyl-alanyl-glycyl-valine using 9-fluorenylmethyloxycarbonylamino acids.
    Meienhofer J; Waki M; Heimer EP; Lambros TJ; Makofske RC; Chang CD
    Int J Pept Protein Res; 1979 Jan; 13(1):35-42. PubMed ID: 422322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human myeloma IgG half-molecules. Structural and antigenic analyses,
    Spiegelberg HL; Heath VC; Lang JE
    Biochemistry; 1975 May; 14(10):2157-63. PubMed ID: 50083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of crystalline glucagon.
    Mojsov S; Merrifield RB
    Biochemistry; 1981 May; 20(10):2950-6. PubMed ID: 7248261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-alkylation of amino acid residues by chloromethyl groups. A potential side reaction in the solid phase peptide synthesis.
    Christensen M; Schou O
    Int J Pept Protein Res; 1978 Sep; 12(3):121-9. PubMed ID: 700919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of protected amino acids and peptides from benzyl ester resins by transesterification with potassium cyanide in benzyl alcohol.
    Moore GJ; Kwok YC
    Can J Biochem; 1980 Aug; 58(8):641-3. PubMed ID: 7459690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).
    Chen BL; Poljak RJ
    Biochemistry; 1974 Mar; 13(6):1295-302. PubMed ID: 4814727
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of solid support, solvent and coupling reagent on the head-to-tail cyclization of resin-bound peptides.
    McMurray JS; Lewis CA; Obeyesekere NU
    Pept Res; 1994; 7(4):195-206. PubMed ID: 7696839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.